Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades22,458
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Company
Research
AZN Company
Timeline
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
14,318.00
256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread:
6.00 (0.042%)
Market Cap:
£222.05b
Last checked at -
Last checked at 
Intraday Astrazeneca Share Chart
Astrazeneca News
7 Nov 2025
UK stocks end week in red as earnings-driven losses weigh
Both FTSE 100, FTSE 250 post weekly decline *
7 Nov 2025
LONDON BROKER RATINGS: Goldman Sachs cuts Weir; UBS ups British Land
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:
6 Nov 2025
UK stocks fall after BoE holds rates, pound gains ground
FTSE 100 down 0.4%, FTSE 250 falls 0.5% *
6 Nov 2025
European stocks fall as tech nerves sap sentiment; earnings, economic data in focus
Novo Nordisk gains after Pfizer's legal setback *
6 Nov 2025
LONDON MARKET CLOSE: FTSE 100 slips amid BoE rate hold, fresh US falls
(Alliance News) - The FTSE 100 fell on Thursday as the Bank of England left interest rates unchanged in a tight vote and investors weighed a deluge of...
6 Nov 2025
AstraZeneca holds forecasts as cancer, heart drugs lift earnings
Full-year revenue, profit growth forecasts unchanged *
6 Nov 2025
With White House deal near, Novo and Lilly shares rise
Novo and Lilly shares rise on expected White House deal *
6 Nov 2025
AstraZeneca beats Q3 expectations, maintains FY outlook
(Sharecast News) - Drugmaker AstraZeneca reiterated its full-year guidance on Thursday as it posted a third-quarter earnings beat, driven by solid sal...
Follow the stocks
